MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression

International Journal of Cancer

Volumn 137, Issue 10, 2015, Pages 2310-2322

  Bai, Rongpan ^a,c   Weng, Chunhua ^a   Dong, Haojie ^a,c   Li, Siqi ^a,c   Chen, Guangdi ^a,c   Xu, Zhengping ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

colorectal cancer; GAB1; microRNA 409 3p; tumor metastasis

Indexed keywords

BINDING PROTEIN; GRB2 ASSOCIATED BINDING PROTEIN 1; MESSENGER RNA; MICRORNA; MICRORNA 409 3P; NUCLEAR RECEPTOR RELATED FACTOR 1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; GAB1 PROTEIN, HUMAN; MIRN409 MICRORNA, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GAB1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LMO4 GENE; METASTASIS INHIBITION; METASTATIC COLORECTAL CANCER; MIGRATION INHIBITION; MOUSE; NONHUMAN; NR4A2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; GENETICS; HCT116 CELL LINE; LUNG TUMOR; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; HCT116 CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION;

EID: 84941936539     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29607     Document Type: Article

References (49)

1. Siegel R, Desantis C, Jemal A,. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-17.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Chaffer CL, Weinberg RA,. A perspective on cancer cell metastasis. Science 2011; 331: 1559-64.
4. Valastyan S, Weinberg RA,. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-92.
5. de Krijger I, Mekenkamp LJ, Punt CJ, et al., MicroRNAs in colorectal cancer metastasis. J Pathol 2011; 224: 438-47.
6. Ji D, Chen Z, Li M, et al., MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer 2014; 13: 86
7. Park SY, Kim H, Yoon S, et al., KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis. Mol Ther 2014; 22: 1653-64.
8. Zhang L, Dong Y, Zhu N, et al., microRNA-139-5p exerts tumor suppressor function by targeting notch1 in colorectal cancer. Mol Cancer 2014; 13: 124
9. Chang TC, Wentzel EA, Kent OA, et al., Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-52.
10. Fujiya M, Konishi H, Mohamed Kamel MK, et al., microRNA-18a induces apoptosis in colon cancer cells via the autophagolysosomal degradation of oncogenic heterogeneous nuclear ribonucleoprotein a1. Oncogene 2014; 33: 4847-56.
11. Hur K, Toiyama Y, Takahashi M, Balaguer F, Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR, Goel A,. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013; 62: 1315-26.
12. Zheng YB, Luo HP, Shi Q, et al., miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting zeb2. World J Gastroenterol 2014; 20: 6515-22.
13. Yamakuchi M, Lotterman CD, Bao C, et al., P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 2010; 107: 6334-9.
14. Yamada N, Tsujimura N, Kumazaki M, et al., Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. Biochim Biophys Acta 2014; 1839: 1256-72.
15. Bonfrate L, Altomare DF, Di Lena M, et al., MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis 2013; 22: 311-20.
16. Bouyssou JM, Manier S, Huynh D, et al., Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta 2014; 1845: 255-65.
17. Schetter AJ, Okayama H, Harris CC,. The role of microRNAs in colorectal cancer. Cancer J 2012; 18: 244-52.
18. Li C, Nie H, Wang M, et al., MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting phf10 in gastric cancer. Cancer Lett 2012; 320: 189-97.
19. Weng C, Dong H, Chen G, Zhai Y, Bai R, Hu H, Lu L, Xu Z,. miR-409-3p inhibits ht1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Lett 2012; 323: 171-9.
20. Zheng B, Liang L, Huang S, et al., MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2012; 31: 4509-16.
21. Josson S, Gururajan M, Hu P, et al., miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer. Clin Cancer Res 2014; 20: 4636-46.
22. Josson S, Gururajan M, Sung SY, et al., Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene 2014; 28:212.
23. Valeri N, Braconi C, Gasparini P, et al., MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell 2014; 25: 469-83.
24. Xu X, Chen H, Lin Y, et al., MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-met. Mol Cells 2013; 36: 62-8.
25. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
26. Maragkakis M, Alexiou P, Papadopoulos GL, et al., Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009; 10: 295
27. Maragkakis M, Reczko M, Simossis VA, et al., DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 2009; 37: W273-6.
28. Wang X, El Naqa IM,. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics 2008; 24: 325-32.
29. Zhou JJ, Zheng S, Sun LF, Zheng L,. MicroRNA regulation network in colorectal cancer metastasis. World J Biol Chem 2014; 5: 301-7.
30. Stiegelbauer V, Perakis S, Deutsch A, et al., MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. World J Gastroenterol 2014; 20: 11727-35.
31. Orang AV, Barzegari A,. MicroRNAs in colorectal cancer: from diagnosis to targeted therapy. Asian Pac J Cancer Prev 2014; 15: 6989-99.
32. Zhao H, Xu Z, Qin H, et al., miR-30b regulates migration and invasion of human colorectal cancer via six1. Biochem J 2014; 460: 117-25.
33. Shen K, Liang Q, Xu K, et al., MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 2012; 84: 320-30.
34. Subramanian M, Rao SR, Thacker P, et al., MiR-29b downregulates canonical wnt signaling by suppressing coactivators of beta-catenin in human colorectal cancer cells. J Cell Biochem 2014; 115: 1974-84.
35. Kasinski AL, Slack FJ,. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-64.
36. Filipowicz W, Bhattacharyya SN, Sonenberg N,. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008; 9: 102-14.
37. Wan L, Zhu L, Xu J, et al., MicroRNA-409-3p functions as a tumor suppressor in human lung adenocarcinoma by targeting c-met. Cell Physiol Biochem 2014; 34: 1273-90.
38. Nishida K, Hirano T,. The role of gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci 2003; 94: 1029-33.
39. Yamasaki S, Nishida K, Yoshida Y, et al., Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene 2003; 22: 1546-56.
40. Gu H, Neel BG,. The «gab» in signal transduction. Trends Cell Biol 2003; 13: 122-30.
41. Sang H, Li T, Li H, et al., Down-regulation of gab1 inhibits cell proliferation and migration in hilar cholangiocarcinoma. PLoS One 2013; 8: e81347
42. Felici A, Giubellino A, Bottaro DP,. Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells. J Cell Biochem 2010; 111: 310-21.
43. Oka M, Kikkawa U, Nishigori C,. Protein kinase C-betaII represses hepatocyte growth factor-induced invasion by preventing the association of adapter protein gab1 and phosphatidylinositol 3-kinase in melanoma cells. J Invest Dermatol 2008; 128: 188-95.
44. Seiden-Long I, Navab R, Shih W, et al., Gab1 but not grb2 mediates tumor progression in met overexpressing colorectal cancer cells. Carcinogenesis 2008; 29: 647-55.
45. Ortiz-Padilla C, Gallego-Ortega D, Browne BC, et al., Functional characterization of cancer-associated gab1 mutations. Oncogene 2013; 32: 2696-702.
46. Nakaoka Y, Komuro I,. Gab docking proteins in cardiovascular disease, cancer, and inflammation. Int J Inflam 2013; 2013: 141068
47. Mraz M, Chen L, Rassenti LZ, et al., miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of gab1 and foxp1. Blood 2014; 124: 84-95.
48. Fan YX, Wong L, Marino MP, et al., Acquired substrate preference for gab1 protein bestows transforming activity to erbb2 kinase lung cancer mutants. J Biol Chem 2013; 288: 16895-904.
49. Trusolino L, Bertotti A, Comoglio PM,. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-48.